CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Open-market sale EVP & Chief Commercial Officer sold 295 shares at $54.78 ($16,160)
- 4 Grant or award Director acquired 5,120 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Chief Accounting Officer sold 132 shares at $84.55 ($11,161)
- 4 Open-market sale CBO & EVP sold 10,281 shares at $67.01 ($688,930)
- 4 Open-market sale EVP and Chief Legal Officer sold 5,140 shares at $62.95 ($323,563)
- 4 Exercise or conversion Director acquired 7,500 shares (option exercise)
- 4 Open-market sale CFO & Executive Vice President sold 954 shares at an average $65.71 ($62,686)
- 4 Open-market sale EVP & Chief Commercial Officer sold 2,713 shares at $66.62 ($180,740)
- 4 Open-market sale Pinion John Richard sold 4,498 shares at $66.62 ($299,657)
- 4 Open-market sale SVP, Chief Accounting Officer sold 843 shares at $66.62 ($56,161)
- 4 Open-market sale Huang Dennis Karl sold 3,234 shares at $66.62 ($215,449)
- 4 Open-market sale EVP and Chief Legal Officer sold 2,886 shares at $66.62 ($192,265)
- 4 Open-market sale CBO & EVP sold 2,374 shares at $66.62 ($158,156)
Page 8 of 32 · 627 filings